1832 Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $74.5M | Buy |
|
|||||
|
2024
Q1 | $5.08M | Sell |
|
|||||
|
2023
Q4 | $5.4M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $82.6M | Buy |
|
|||||
|
2022
Q3 | $50.4M | Buy |
|
|||||
|
2022
Q2 | $7.54M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $25.5M | Sell |
|
|||||
|
2020
Q1 | $49.9M | Sell |
|
|||||
|
2019
Q4 | $67.3M | Buy |
|
|||||
|
2019
Q3 | $46.8M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $79.2M | Buy |
|
|||||
|
2018
Q2 | $37M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $4.92M | Buy |
|